Determination and pharmacokinetic study of norcantharidin in human serum by HPLC-MS/MS method

Biomedical Chromatography

Volumn 22, Issue 1, 2008, Pages 44-49

  Wei, Chun Min ^a   Zhang, Rui ^a   Wang, Ben Jie ^a   Yuan, Gui Yan ^a   Guo, Rui Chen ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Cyclophosphamide; HPLC MS MS; Norcantharidin; Pharmacokinetic

Indexed keywords

ACETONE; BODY FLUIDS; ELECTROSPRAY IONIZATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; POSITIVE IONS;

AMMONIUM ACETATE; CYCLOPHOSPHAMIDE; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; HPLC-MS-MS; HUMAN SERUM; MOBILE PHASIS; NORCANTHARIDIN; PHARMACOKINETIC STUDIES; REVERSED-PHASE COLUMNS; SIMPLE++;

PHARMACOKINETICS;

ACETONE; ACETONITRILE; AMMONIUM ACETATE; CYCLOPHOSPHAMIDE; FORMIC ACID; NORCANTHARIDIN;

ACCURACY; ADULT; AREA UNDER THE CURVE; ARTICLE; CALIBRATION; CHINESE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DETERMINATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG ISOLATION; DRUG RETENTION; ELUTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; MORNING DOSAGE; NORMAL HUMAN; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE; SOLVENT EXTRACTION; TANDEM MASS SPECTROMETRY; TIME TO MAXIMUM PLASMA CONCENTRATION; VOLUNTEER;

EID: 38749102692     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.892     Document Type: Article

References (6)

1. Hart ME, Chamberlin R, Walkom C, Sakoff JA and McCluskey A. Modified norcantharidins: synthesis, protein phosphatases 1 and 2A inhibition, and anticancer activity. Bioorganic and Medicinal Chemistry Letters 2004; 14(8): 1969-1973.
2. Shao R and Tang X. HPLC-MS determination of norcantharidin in rat plasma. Chinese Journal of Pharmaceutical Analysis 2005; 25(6): 607-609.
3. Wang GS. Medical uses of mylabris in ancient China and recent studies. Journal of Ethnopharmacology 1989; 26(2): 147-162.
4. Wang L, He H, Tang X, Shao R and Chen D. A less irritant norcantharidin lipid microspheres: formulation and drug distribution. International Journal of Pharmaceutics 2006; 323(1-2): 161-167.
5. Zhang L, Xiang D, Hong Z and Zhang Z. Studies on the liver targeting of norcantharindin microemulsion. Acta Pharmaceutica Sinica 2004; 39(8): 650-655.
6. Zhao Z, Fan Y, Chen C and Fu J. Effect in vivo of norcantharidin on proliferation and growth of implanted tumors of human gallbladder carcinoma in nude mice. Chinese Journal of New Drugs and Clinical Remedies 2006; 25(2): 98-103.